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Supplemental Materials and Methods
Plasmid and strain construction.
All primers used in this study are listed in Table S1 and strains are listed in Table 1 . The ykrL deletion was constructed as follows. First, the ykrL locus including 735 bp upstream the start codon and 584 bp downstream the stop codon, was amplified using primers ykrLdel-fw and ykrLdel-rv. The PCR product was ligated into pCR2.1-TOPO (Invitrogen). The resulting vector, pTOPO-DykrL-1, was digested with SwaI and Eco47III enzymes. The spectinomycin resistance gene was amplified from pDG1726 (3) using primers specBsu-F and specBsu-R and ligated into pTOPO-DykrL-1. The resulting plasmid pTOPO-DykrL-2 carries ykrL flanking regions and the spectinomycin resistance gene replacing 874 bp of the ykrL gene. Strain JW8940 was constructed by transforming JW8900 with pTOPO-DykrL-2 resulting in replacement of the ykrL gene with the spectinomycin cassette by double recombination.
The sigW deletion mutant was constructed as follows. The sigW locus including 540 bp upstream the start codon and 376 bp downstream the stop codon was amplified using primers sigW-del-fw and sigW-del-rv.
The PCR product was ligated into pCR2.1-TOPO (Invitrogen) resulting in pTOPO-DsigW-1. Next, the kanamycin resistance marker was amplified from pDG780 (3) using the primers Km-dsigW-fw and Km-dsigW-rv. After digestion with SacI and AccI, the product was ligated into pTOPO-DsigW-1, from which a 374 bp internal fragment of sigW was removed by digestion with the same enzymes. The resulting vector, pTOPO-DsigW-2 was transformed to the B. subtilis RH100, giving rise to strain KB100 which contains the kanamycin resistance cassette replacing the 374 bp internal sigW fragment.
To disrupt a ykrK, the deletion construct pDG1514-ykrK was made in two steps. An upstream flanking region of ykrK was amplified with primers ykrK::tc-o1 and ykrK::tc-o2, digested with BamHI and PstI and ligated to the corresponding sites of pDG1514 (3), upstream the tetracycline resistance cassette. Next, 2 a downstream flanking region of ykrK was amplified with primers ykrK::tc-o3 and ykrK::tc-o4, digested with HindIII and XhoI and ligated at the same sites downstream the resistance cassette, resulting in pDG1514-ykrK. The construct was then transformed to BC400 and BC401, which gave strains BC402 and BC403, respectively, with a disrupted ykrK gene.
The PykrL-gfp reporter strains were obtained as follows. First, a DNA fragment of 510 bp upstream of ykrL containing the promoter region of ykrL was amplified using primers PykrL-fw and PykrL-rv. The PCR product was digested with KpnI and PstI and ligated into the same sites of pSG1151 (6) , which resulted in pPykrL-gfp. pPykrL-gfp was transformed to the strains 168 and RH100 resulting, by means of Campbell-type integration, in strains BC400 and BC300, respectively.
The BC401 strain carrying the PykrL-gfp fusion and rok deletion was made by transforming BC400 with chromosomal DNA from B. subtilis BD3196, carrying a rok mutation (1).
Strain HT400 was constructed as follows. A 463 bp ykrL promoter region of B. subtilis was amplified using primers PykrLpDL-fw and PykrLpDL-rv, digested with BamHI and KpnI and ligated upstream of the -galactosidase gene (bgaB) in pDL, an amyE integration vector (8) , which was cut with corresponding enzymes. The resulting plasmid pDL-PykrL was transformed to B. subtilis 168, resulting in integration of the PykrL-bgaB (PykrL-lacZ) fusion in the amyE locus.
Plasmid pNZ-ykrK-strep was made by amplifying ykrK using primers ykrK-strep-F and ykrK-strep-R carrying the Strep-tag sequence for a C-terminal fusion. The product was digested with PagI and KpnI and ligated into pNZ8948 (4), cut beforehand with NcoI and KpnI.
To construct pNZ-ykrK, ykrK gene was amplified using primers ykrK-fw and ykrK-rv. The product was digested with PagI and HindIII and ligated into pNZ8902 digested with NcoI and HindIII.
To make pNZ-xylP, xylP of Lactobacillus pentosus was amplified using primers xylP-fw and xylP-rv.
The PCR product was digested with PagI and XbaI and ligated into pNZ8902 digested with NcoI and XbaI.
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DNA Microarray analysis.
The transcriptional profile of B. subtilis NZ8900 carrying pNZ-ykrK was compared to the profile of strain NZ8900 strain carrying the empty vector pNZ8902. For ykrK induction, SURE expression system was used (2) . Strains were grown in TY broth and at OD 600 of 0.8, 0.1% subtilin was added to both cultures.
After 30 minutes further incubation, 10 OD units (1 OD 600 unit corresponds to 1 ml of a culture of an OD 600 of 1.0) of each culture was collected for RNA isolation. The microarray experiment was performed in three biological replicates and one technical replicate.
RNA isolation, amino allyl-modified cDNA synthesis, cDNA labeling with Cy3 and Cy5 dyes, hybridization to oligonucleotide microarrays, washing, scanning, image analysis and normalization of data as well as statistical analysis were performed as described previously (7) . 
Transposon mutagenesis
Detection of transposition events. Random mutagenesis of the B. subtilis strain HT400 was performed using the TnYLB-1 transposon following the protocol described before (5) with modifications. The HT400 strain was transformed with pMarA carrying the TnYLB-1 transposon. Transformants were selected on plates for erythromycin resistance at 30°C, permissive for plasmid replication. A positive clone was grown for three hours at 30°C, whereupon the temperature was shifted to 45°C (nonpermissive temperature) and grown for additional 4 hours. Proper dilutions were plated on TY agar containing 5 g ml -1 kanamycin and 0.01 % X-gal (5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside, Sigma) and 4 incubated at 45°C. To confirm that the transposition event was efficient, the same dilutions were plated on TY agar containing 1 g ml -1 erythromycin.
Identification of transposon insertion sites. 1 g of chromosomal DNA from transposon mutants was
digested with TaqI or HindIII, purified and circularized in a ligation reaction using T4 DNA ligase. 100 ng of ligated DNA was used as a template for inverse-PCR (iPCR) using primers oIPCR1 and oIPCR2 (5) . iPCR products were purified and sequenced with oIPCR3 primer (5) by ServiceXS (Leiden, The Netherlands). 
